Literature DB >> 33814837

Contemporary Outcomes of Open Radical Cystectomy: a 5-Year Experience from a Tertiary Care Center.

Brusabhanu Nayak1, Harshit Garg1, Ritesh Goel1, Prabhjot Singh1, Rishi Nayyar1, Rajeev Kumar1, Amlesh Seth1.   

Abstract

To evaluate the perioperative outcomes of patients undergoing open radical cystectomy for carcinoma bladder in a tertiary care center. A retrospective analysis of a prospectively maintained database of all patients undergoing open radical cystectomy with a urinary diversion from July 2014 to August 2019 was done. A total of 195 patients were included. A total of 172 patients (88.2%) underwent radical cystectomy with ileal or sigmoid conduit, 6 patients underwent orthotopic neobladder, and 17 patients underwent cutaneous ureterostomy. The mean American Society of Anaesthesiology (ASA) score was 1.4. On preoperative histopathology, 125 patients had the muscle-invasive disease. The mean operative time (± SD) was 303.6 ± 53.4 min and the operative time was significantly longer for neobladder (p = 0.033). The mean blood loss (± SD) was 977.5 ± 346.5 ml. Among the complications, a total of 350 events occurred in 96 patients (49.3%). Thirty-nine patients (20%) suffered grade I complications, 12 patients (6.2%) suffered grade II complications, 26 patients (13.3%) suffered grade III complications, and 9 patients (4.6%) suffered grade IV complications. Grade III, IV, and V complications were considered major complications and 46 patients (23.5%) had major complications. Among the grade III complications, the majority included fascial dehiscence (burst abdomen), i.e., 13.3%, and uretero-ileal leak, i.e., 2.6%. The overall 30-day mortality rate was 5.2% (10/195). On multivariate analysis, the presence of diabetes mellitus (p = 0.047), operative time (p = 0.003), and low preoperative albumin (p = 0.009) were significant predictors for major preoperative complications. Diabetes mellitus, serum albumin, and operative time are significant predictors of postoperative complications. The ASA score, low preoperative hemoglobin, and blood loss are significant predictors of perioperative mortality. Though radical cystectomy has been associated with significant perioperative morbidity and mortality, the advancements in surgical techniques and intensive care tools have led to a significant decrease in morbidity and mortality in the contemporary era. © Indian Association of Surgical Oncology 2021.

Entities:  

Keywords:  Carcinoma bladder; Ileal conduit; Open radical cystectomy; Orthotopic neobladder; Perioperative complications

Year:  2021        PMID: 33814837      PMCID: PMC7960850          DOI: 10.1007/s13193-020-01226-z

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  26 in total

1.  Oncologic outcomes after robot-assisted versus open radical cystectomy: a systematic review and meta-analysis.

Authors:  Takehiro Iwata; Shoji Kimura; Beat Foerster; Nicola Fossati; Alberto Briganti; Pierre I Karakiewicz; Kilian M Gust; Shin Egawa; Yasutomo Nasu; Mohammad Abufaraj; Shahrokh F Shariat
Journal:  World J Urol       Date:  2019-04-11       Impact factor: 4.226

2.  Ten-Year Oncologic Outcomes Following Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium.

Authors:  Ahmed A Hussein; Ahmed S Elsayed; Naif A Aldhaam; Zhe Jing; Jennifer Osei; Jihad Kaouk; Juan Palou Redorta; Mani Menon; James Peabody; Prokar Dasgupta; Mohammed Shamim Khan; Alexandre Mottrie; Michael Stöckle; Ashok Hemal; Lee Richstone; Abolfazl Hosseini; Peter Wiklund; Francis Schanne; Eric Kim; Koon Ho Rha; Khurshid A Guru
Journal:  J Urol       Date:  2019-10-09       Impact factor: 7.450

3.  Bladder cancer with obstructive uremia: oncologic outcome after definitive surgical management.

Authors:  Nasr A El-Tabey; Yasser Osman; Ahmed Mosbah; Tarek Mohsen; Hassan Abol-Enein
Journal:  Urology       Date:  2005-09       Impact factor: 2.649

4.  The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.

Authors:  Stephen B Edge; Carolyn C Compton
Journal:  Ann Surg Oncol       Date:  2010-06       Impact factor: 5.344

5.  Nutritional predictors of complications following radical cystectomy.

Authors:  David C Johnson; Stephen B Riggs; Matthew E Nielsen; Jonathan E Matthews; Michael E Woods; Eric M Wallen; Raj S Pruthi; Angela B Smith
Journal:  World J Urol       Date:  2014-09-21       Impact factor: 4.226

6.  Oncological and functional outcome of radical cystectomy in patients with bladder cancer and obstructive uropathy.

Authors:  Narmada P Gupta; Surendra B Kolla; A Seth; Ashok K Hemal; Prem N Dogra; R Kumar
Journal:  J Urol       Date:  2007-08-14       Impact factor: 7.450

7.  Neoadjuvant chemotherapy use in bladder cancer: a survey of current practice and opinions.

Authors:  N G Cowan; Y Chen; T M Downs; B H Bochner; A B Apolo; M P Porter; J C La Rochelle; C L Amling; T M Koppie
Journal:  Adv Urol       Date:  2014-05-28

8.  An audit of early complications of radical cystectomy using Clavien-Dindo classification.

Authors:  Nitesh Patidar; Priyank Yadav; Sanjoy Kumar Sureka; Varun Mittal; Rakesh Kapoor; Anil Mandhani
Journal:  Indian J Urol       Date:  2016 Oct-Dec

9.  Disparities in the Use of Continent Urinary Diversions after Radical Cystectomy for Bladder Cancer.

Authors:  Nicholas J Farber; Izak Faiena; Viktor Dombrovskiy; Alexandra L Tabakin; Brian Shinder; Rutveej Patel; Sammy E Elsamra; Thomas L Jang; Eric A Singer; Robert E Weiss
Journal:  Bladder Cancer       Date:  2018-01-20

10.  Robot-assisted laparoscopic radical cystectomy with extracorporeal urinary diversion: Initial experience and outcomes.

Authors:  Nitin Shrivastava; Brusabhanu Nayak; Premnath Dogra; Rajeev Kumar; Prabhjot Singh
Journal:  Indian J Urol       Date:  2018 Apr-Jun
View more
  1 in total

1.  Late Spontaneous Rupture of the Orthotopic Neobladder, an Unusual Complication.

Authors:  Nour Khalil; Eddy Lilly; Marwan Alkassis; Raymond Mansour; Georges Abi Tayeh; Julien Sarkis; Fouad Aoun
Journal:  Indian J Surg Oncol       Date:  2021-09-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.